SynthesisJournal of the American Heart Association2014

Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.

Jonathan Douxfils et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.